NASDAQ:TSHA | Key Financial Ratios | Taysha Gene Therapies, Inc.

Complete source-backed ratio history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-3017.76-31.81%-38.64%
2026-03-3114.04-43.24%-61.28%
2025-12-3112.23-31.75%-44.14%
2025-09-3010.48-31.57%-45.63%
2025-06-3012.48-27.82%-37.28%
2025-03-315.35-62.71%-157.59%
2024-12-315.42-55.68%-124.85%
2024-09-305.51-12.64%-25.65%
2024-06-305.22-57.06%-105.02%
2024-03-313.38-77.13%-219.14%
2023-12-314.08-64.59%-148.88%
2023-09-300.95-109.51%436.50%
2023-06-301.07-151.85%333.63%
2023-03-311.33-131.22%891.89%
2022-12-311.54-131.47%-17493.57%
2022-09-301.3-144.72%-1507.26%
2022-06-301.79-130.67%-572.13%
2022-03-312.2-116.17%-380.00%
2021-12-313.08-81.57%-182.97%
2021-09-304.56-59.10%-101.47%
2021-06-307.3-43.96%-57.00%
2021-03-3112.64-35.66%-38.86%
2020-12-3136.17-23.18%-23.88%
2020-09-3024.02
2019-12-310.1

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-3112.23-31.75%-44.14%
2024-12-315.42-55.68%-124.85%
2023-12-314.08-64.59%-148.88%
2022-12-311.54-131.47%-17493.57%
2021-12-313.08-81.57%-182.97%
2020-12-3136.17-23.18%-23.88%
2019-12-310.1

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.